Mazen Animal Health - Oral Vaccines Revenue and Competitors

Ames, IA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Mazen Animal Health - Oral Vaccines's estimated annual revenue is currently $1.8M per year.(i)
  • Mazen Animal Health - Oral Vaccines's estimated revenue per employee is $77,500

Employee Data

  • Mazen Animal Health - Oral Vaccines has 23 Employees.(i)
  • Mazen Animal Health - Oral Vaccines grew their employee count by 44% last year.

Mazen Animal Health - Oral Vaccines's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
VP Research and DevelopmentReveal Email/Phone
3
Quality DirectorReveal Email/Phone
4
Director FinanceReveal Email/Phone
5
Director Regulatory AffairsReveal Email/Phone
6
Field Manager - CaliforniaReveal Email/Phone
7
Senior Research ScientistReveal Email/Phone
8
Research Scientist, Molecular BiologistReveal Email/Phone
9
Business Administration LeadReveal Email/Phone
10
Senior Principal Scientist, Biochemistry LeadReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.9M6-14%N/AN/A
#2
$16.1M1049%N/AN/A
#3
$0.8M10-44%$2.1MN/A
#4
$504.4M20341%$31.2MN/A
#5
$8.1M526%N/AN/A
#6
$2M130%N/AN/A
#7
$0.3M2-85%N/AN/A
#8
$0.2M10%N/AN/A
#9
$1.8M2344%N/AN/A
#10
$1.4M9-10%N/AN/A
Add Company

What Is Mazen Animal Health - Oral Vaccines?

Mazen Animal Health, Inc. is a biotechnology company transforming corn seed into the future of animal vaccines. We have produced proof of efficacy data in two vaccine candidates, each addressing a significant unmet need. By creating vaccines to be delivered orally with animal feed, Mazen provides elegant solutions to the challenges associated with injectable vaccines with:(1) increased production system ROI - removing the economic thresholds that control the vaccination decision today; (2) a safer method of vaccine administration for both animals and workers; (3) optimized vaccine efficacy allowing for reduced antibiotic use; and (4) vaccines with a global reach because of ambient temperature stability and ease of delivery. Mazen’s platform technology expresses antigens in corn seed and improves the standard vaccine manufacturing cost structure. These safe subunit antigen vaccines protect the animal by creating both mucosal and systemic immunity which should increase efficacy compared with current injectable vaccines. Corn seed containing antigen is ground into meal and added to animal feed. Cost effective disease prevention benefits the environment with decreased losses and increased productivity of protein to feed our planet. For more information, visit us at www.mazenanimalhealth.com, or follow us on Twitter at twitter.com/mazenanimal.

keywords:N/A

N/A

Total Funding

23

Number of Employees

$1.8M

Revenue (est)

44%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.3M23N/AN/A
#2
$4.3M2310%N/A
#3
$2.3M2315%N/A
#4
$4.7M23-48%N/A
#5
$2.4M24N/AN/A